microscope

Data Protection and AI Compliance for Biotech

 

Biotech is revolutionising healthcare, driven by scientific breakthroughs and AI-powered innovation. The COVID-19 pandemic put biological science in the global spotlight, and now, AI is accelerating the development of life-changing treatments.

 

Book a free consultation

But with great innovation comes great responsibility.

Success in biotech depends on more than just groundbreaking research—it requires robust data protection and AI compliance to:

  • Protect patient data
  • Gain NHS and stakeholder trust
  • Attract vital investment
  • Mitigate cyber risks that could threaten critical research

Achieving and demonstrating compliance with evolving data protection and AI regulations is complex – but essential. That’s where NormCyber comes in.

Meet NormCyber

As an award-winning provider of data protection and AI compliance expertise, we help biotech companies navigate regulatory challenges with confidence. From risk assessments and compliance frameworks to policy reviews, training, and cyber security solutions, we empower you with the clarity, control, and resilience needed to protect your most valuable asset: data.

Why Biotech Companies Trust NormCyber

Expert Guidance. Tailored Solutions. Cost-Effective Compliance.

01

Compliance Made Simple

Our lawyer-led team of privacy professionals and certified GDPR experts ensure you understand and meet your obligations under the UK GDPR, EU GDPR, and the EU AI Act—without the complexity.

02

Sector-Specific Expertise

We work with leading biotech companies like Brainomix to look after their data protection and AI compliance, so they can focus on delivering life-changing innovation.

03

Personalised Support

We act as an extension of your team, developing a deep understanding of your business to provide tailored advice, guidance and support.

04

Minimising Risk & Maximising Security

We take a proactive approach to compliance, helping you reduce regulatory penalties, and operational disruptions.

05

Cost-Efficient Expertise

Outsourcing your data protection and AI compliance to NormCyber is up to 70% more cost-effective than hiring an in-house expertise or relying on external law firms.

06

Award-Winning Solutions

Recognised at the PICCASO Privacy Awards Europe 2024, NormCyber is trusted by biotech leaders and healthcare innovators.

Flexible Packages to Suit Your Needs

Choose from three tailored tiers of support. Whichever option you select, you’ll work closely with a dedicated Data Protection team to create a robust and effective data privacy framework.

View packages

Common Data Protection and AI Challenges for
Biotech Companies

Roles and Responsibilities

Understanding your role in relation to the personal data you are processing is crucial in ensuring compliance with the UK and EU GDPRs. Your obligations will vary depending on whether you are a ‘controller’, ‘joint controller’ or ‘processor’.

Privacy

Patients and other individuals have the right to be informed about the collection and use of their personal data. Biotech companies need to know what ‘privacy information’ to provide, when and how.

AI

Now that the EU AI Act is in force, biotech companies wanting to do business in the EU need to understand the roles of ‘Providers’ or ‘Deployers’ – and the differing obligations and responsibilities that go with these rolls, as well as which risk category their product will be classified as.

Investor Confidence

Part of raising money to fund development and research often involves answering difficult due diligence questions from potential investor’s about data protection compliance.

Contracts

Both the UK and EU GDPRs imposes a legal obligation on organisations sharing patient personal data to formalise their working relationship by having a contract in place with required terms, ensuring they each protect the personal data of patients and other individuals; ensure both are clear about their role and responsibilities – and are able to demonstrate this.

Data Transfers

Sharing personal data with other organisations that are outside the UK or EU adds another, sometimes daunting, layer of complexity to contracts.

Risk Assessment

Data Protection Impact Assessments (DPIAs) are a process designed to help systematically analyse, identify and minimise the data protection risks of a project or plan. They are also key to compliance with the EU AI Act. But DPIAs can be very time-consuming and very often are carried out with only a focus on technical security, without much or any consideration given to lawful bases.

Anonymisation and pseudonymisation

Understanding the difference between these, their impact on data protection compliance requirements, and how their use can assist with safeguarding patient personal data is essential.

Research

Knowing when you can use personal data for research.

Norm ensures

brainomix logo

Customer Success Story:
Brainomix

Brainomix, a leader in AI-powered imaging solutions, appointed NormCyber to ensure full data protection compliance. With our advice, guidance and support, Brainomix can focus on delivering life-saving AI innovations.

Read the full case study

Trusted by Industry Leaders

Biotech and healthcare innovators trust NormCyber for their data protection needs.

“Norm has given us clarity in where we are with our data protection and information security health, and where we need to be as we reach new levels of growth. Robert and his team are extremely knowledgeable and happy to work around our needs in a mindful and pragmatic manner, which makes them feel truly part of our team.”

Melissa Strange

Chief Financial Offer | Brainomix

Brainomix logo.

“Data privacy is a top priority for us, so we knew it was time to bring experts in. Norm was recommended to us, and after speaking with the team, we were ready to try it their way. We haven’t looked back since!”

Alice Facey

Chief of Staff | 111SKIN

111Skin Logo.

Don’t Delay,
Act Today and Take the Next Step

 

Empower your biotech business with award-winning
data protection from NormCyber.

 

Book a meeting